Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
The threat from antimicrobial resistance (AMR) continues to grow. Japan’s National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-rel...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d06e553c127f4598a89deee3c8ea94ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d06e553c127f4598a89deee3c8ea94ae |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d06e553c127f4598a89deee3c8ea94ae2021-11-25T16:22:13ZOutcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)10.3390/antibiotics101112932079-6382https://doaj.org/article/d06e553c127f4598a89deee3c8ea94ae2021-10-01T00:00:00Zhttps://www.mdpi.com/2079-6382/10/11/1293https://doaj.org/toc/2079-6382The threat from antimicrobial resistance (AMR) continues to grow. Japan’s National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-related surveillance, and we now know the situation regarding antimicrobial use and antimicrobial-resistant bacteria in the country. Educational and awareness-raising activities for medical professionals and the general public have been actively implemented and seem to have contributed to a gradual move toward an appropriate use of antimicrobials. However, there is still insufficient understanding of the issue among the general public. Determining how to use surveillance results and implementing further awareness-raising activities are crucial to address this. Tasks for the future include both raising awareness and the promotion of AMR research and development and international cooperation. The government’s next Action Plan, which will detail future countermeasures against AMR based on the outcomes of and tasks identified in the current Action Plan, has been delayed due to the COVID-19 pandemic and is urgently awaited.Yoshiaki GuYumiko FujitomoNorio OhmagariMDPI AGarticleantimicrobial resistance (AMR)public healthaction planpublic awarenesssurveillanceantimicrobial stewardshipTherapeutics. PharmacologyRM1-950ENAntibiotics, Vol 10, Iss 1293, p 1293 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
antimicrobial resistance (AMR) public health action plan public awareness surveillance antimicrobial stewardship Therapeutics. Pharmacology RM1-950 |
spellingShingle |
antimicrobial resistance (AMR) public health action plan public awareness surveillance antimicrobial stewardship Therapeutics. Pharmacology RM1-950 Yoshiaki Gu Yumiko Fujitomo Norio Ohmagari Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020) |
description |
The threat from antimicrobial resistance (AMR) continues to grow. Japan’s National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-related surveillance, and we now know the situation regarding antimicrobial use and antimicrobial-resistant bacteria in the country. Educational and awareness-raising activities for medical professionals and the general public have been actively implemented and seem to have contributed to a gradual move toward an appropriate use of antimicrobials. However, there is still insufficient understanding of the issue among the general public. Determining how to use surveillance results and implementing further awareness-raising activities are crucial to address this. Tasks for the future include both raising awareness and the promotion of AMR research and development and international cooperation. The government’s next Action Plan, which will detail future countermeasures against AMR based on the outcomes of and tasks identified in the current Action Plan, has been delayed due to the COVID-19 pandemic and is urgently awaited. |
format |
article |
author |
Yoshiaki Gu Yumiko Fujitomo Norio Ohmagari |
author_facet |
Yoshiaki Gu Yumiko Fujitomo Norio Ohmagari |
author_sort |
Yoshiaki Gu |
title |
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020) |
title_short |
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020) |
title_full |
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020) |
title_fullStr |
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020) |
title_full_unstemmed |
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020) |
title_sort |
outcomes and future prospect of japan’s national action plan on antimicrobial resistance (2016–2020) |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/d06e553c127f4598a89deee3c8ea94ae |
work_keys_str_mv |
AT yoshiakigu outcomesandfutureprospectofjapansnationalactionplanonantimicrobialresistance20162020 AT yumikofujitomo outcomesandfutureprospectofjapansnationalactionplanonantimicrobialresistance20162020 AT norioohmagari outcomesandfutureprospectofjapansnationalactionplanonantimicrobialresistance20162020 |
_version_ |
1718413228008013824 |